These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 25113585)
1. Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever, Jamaica. Thompson SB; Brown CH; Edwards AM; Lindo JL Pathog Glob Health; 2014 Jul; 108(5):229-34. PubMed ID: 25113585 [TBL] [Abstract][Full Text] [Related]
2. Poor long-term adherence to secondary penicillin prophylaxis in children with history of rheumatic fever. Amarilyo G; Chodick G; Zalcman J; Koren G; Levinsky Y; Somekh I; Harel L Semin Arthritis Rheum; 2019 Jun; 48(6):1019-1024. PubMed ID: 30415945 [TBL] [Abstract][Full Text] [Related]
3. Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study. Gasse B; Baroux N; Rouchon B; Meunier JM; Frémicourt ID; D'Ortenzio E BMC Public Health; 2013 Feb; 13():131. PubMed ID: 23402561 [TBL] [Abstract][Full Text] [Related]
4. Clinic factors associated with better delivery of secondary prophylaxis in acute rheumatic fever management. Quinn E; Girgis S; Van Buskirk J; Matthews V; Ward JE Aust J Gen Pract; 2019 Dec; 48(12):859-865. PubMed ID: 31774991 [TBL] [Abstract][Full Text] [Related]
5. How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease. de Dassel JL; de Klerk N; Carapetis JR; Ralph AP J Am Heart Assoc; 2018 Dec; 7(24):e010223. PubMed ID: 30561268 [TBL] [Abstract][Full Text] [Related]
7. Prophylactic penicillin by the full moon: a novel approach in Central Australia that may help to reduce the risk of rheumatic heart disease. Kearns TM; Schultz R; McDonald V; Andrews RM Rural Remote Health; 2010; 10(3):1464. PubMed ID: 20795756 [TBL] [Abstract][Full Text] [Related]
8. Secondary prevention for screening detected rheumatic heart disease: opportunities to improve adherence. Engelman D; Ah Kee M; Mataika RL; Kado JH; Colquhoun SM; Tulloch J; Steer AC Trans R Soc Trop Med Hyg; 2017 Apr; 111(4):154-162. PubMed ID: 28673022 [TBL] [Abstract][Full Text] [Related]
9. 50 Years Ago in TheJournal ofPediatrics: Why Patients Don't Follow Medical Advice: A Study of Children on Long-Term Antistreptococcal Prophylaxis. Sobotka SA; Ross LF J Pediatr; 2019 Dec; 215():63. PubMed ID: 31761146 [No Abstract] [Full Text] [Related]
10. Efficacy of an incentive intervention on secondary prophylaxis for young people with rheumatic fever: a multiple baseline study. Oetzel JG; Lao C; Morley M; Penman K; Child M; Scott N; Karalus M BMC Public Health; 2019 Apr; 19(1):385. PubMed ID: 30953495 [TBL] [Abstract][Full Text] [Related]
11. Adherence to secondary prevention of rheumatic fever and rheumatic heart disease in young people: an 11-year retrospective study. Liaw J; Gorton S; Heal C; White A Aust N Z J Public Health; 2022 Dec; 46(6):758-763. PubMed ID: 35616403 [TBL] [Abstract][Full Text] [Related]
12. Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever. Kevat PM; Gunnarsson R; Reeves BM; Ruben AR J Paediatr Child Health; 2021 Mar; 57(3):419-424. PubMed ID: 33340191 [TBL] [Abstract][Full Text] [Related]
13. Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14-21 in New Zealand: a framework method study. Barker H; Oetzel JG; Scott N; Morley M; Carr PEA; Oetzel KB Int J Equity Health; 2017 Nov; 16(1):201. PubMed ID: 29149897 [TBL] [Abstract][Full Text] [Related]
14. Adherence to secondary antibiotic prophylaxis for patients with rheumatic heart disease diagnosed through screening in Fiji. Engelman D; Mataika RL; Kado JH; Ah Kee M; Donath S; Parks T; Steer AC Trop Med Int Health; 2016 Dec; 21(12):1583-1591. PubMed ID: 27730711 [TBL] [Abstract][Full Text] [Related]
15. Acute rheumatic fever: adherence to secondary prophylaxis and follow up of Indigenous patients in the Katherine region of the Northern Territory. Stewart T; McDonald R; Currie B Aust J Rural Health; 2007 Aug; 15(4):234-40. PubMed ID: 17617086 [TBL] [Abstract][Full Text] [Related]
16. The Rheumatic Fever and Rheumatic Heart Disease Control programme--Jamaica. Millard-Bullock D West Indian Med J; 2012 Jul; 61(4):361-4. PubMed ID: 23240469 [TBL] [Abstract][Full Text] [Related]
17. Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease: A Literature Review with a Global Perspective. Rémond MG; Coyle ME; Mills JE; Maguire GP Cardiol Rev; 2016; 24(2):94-8. PubMed ID: 25807106 [TBL] [Abstract][Full Text] [Related]
18. Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening. Culliford-Semmens N; Tilton E; Webb R; Lennon D; Paku B; Malcolm J; French S; Blair N; Wilson N N Z Med J; 2017 Jun; 130(1457):50-57. PubMed ID: 28617789 [TBL] [Abstract][Full Text] [Related]
19. Effect of benzathine penicillin treatment on antibiotic susceptibility of viridans streptococci in oral flora of patients receiving secondary prophylaxis after rheumatic fever. Bilavsky E; Eliahou R; Keller N; Yarden-Bilavsky H; Harel L; Amir J J Infect; 2008 Apr; 56(4):244-8. PubMed ID: 18295897 [TBL] [Abstract][Full Text] [Related]
20. Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever. Wyber R; Boyd BJ; Colquhoun S; Currie BJ; Engel M; Kado J; Karthikeyan G; Sullivan M; Saxena A; Sheel M; Steer A; Mucumbitsi J; Zühlke L; Carapetis J Drug Deliv Transl Res; 2016 Oct; 6(5):572-8. PubMed ID: 27465618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]